logo
Share SHARE
FONT-SIZE Plus   Neg

Amgen Agrees To Buy 95.6% Of Shares In Turkey's Mustafa Nevzat - Quick Facts

Amgen (AMGN: Quote) said it agreed to buy acquire 95.6 percent of shares in Mustafa Nevzat Pharmaceuticals, a privately held Turkish pharmaceutical company, for an an amount that values Mustafa Nevzat at $700 million. The all-cash transaction will significantly expand Amgen's presence in Turkey and the surrounding region, which are large, fast-growing, priority markets for Amgen.

Mustafa Nevzat, or MN, had revenues of approximately $200 million in 2011 and has grown on average at double-digit rates in local currency over the past five years.

"This transaction represents an attractive opportunity for MN, its employees and customers," said Levent Selamoglu, general manager and chief executive officer of MN. "The combination of MN and Amgen creates an innovation leader in Turkey with unique capabilities and scope to expand regionally and in other attractive high-growth markets. Amgen's focus and resources will also ensure continued investment in Turkey."

The transaction has been approved by the Board of Directors of each company. Completion of the transaction is subject to customary closing conditions, including regulatory approvals.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Electronic Arts Inc. (EA) on Tuesday reported an increase in profit for the fourth quarter, reflecting continued strong demand from gamers for titles compatible with new-gen consoles and better digital revenues, with both earnings and revenues topping Wall Street estimates. Redwood City, California-based... Daily deals site Groupon Inc said Tuesday after the markets closed that its first quarter loss narrowed from last year, as revenue increased and operating expenses fell. The company's quarterly earnings per share, excluding item, also came in above analysts' expectations, but its quarterly revenue fell short of analysts' forecast. Mylan reported a plunge in profit, hurt by acquisition costs and a stronger dollar. However, quarterly earnings topped Wall Street estimates, while sales missed expectations despite growth across all regions.
comments powered by Disqus
RELATED NEWS
Trade AMGN now with 
Follow RTT